#16
|
||||
|
||||
Öèòàòà:
__________________
Ã.À. Ìåëüíè÷åíêî |
#17
|
|||
|
|||
Åñëè áû çà äâà ãîäà ìîé î÷íûé ãèíåêîëîã õîòü ÷òî-íèáóäü ñäåëàë, ÿ áû íà ôîðóìàõ íå ñèäåëà..........
|
#18
|
|||
|
|||
 ôåâðàëå, ñðåäè äðóãèõ ðåçóëüòàòîâ àíàëèçîâ íà ãîðìîíû, îáíàðóæèëñÿ íèçêèé òòã= 0,007, íà óçè íîâîîáðàçîâàíèÿ â ëåâîé äîëå ñ êàìåðàìè. 31.03.2015 äîêòîð âûïèñàëà òèðîçîë, íà÷àëî ïðèåìà ñ 01.04.2015ã. 10 ìã òðèæäû â äåíü. Ïðèøëè íîâûå äàííûå îò 19.04.2015ã. âî âêëàäêå. Î ÷åì îíè ãîâîðÿò?
|
#19
|
||||
|
||||
__________________
Ã.À. Ìåëüíè÷åíêî |
#20
|
||||
|
||||
__________________
Ã.À. Ìåëüíè÷åíêî |
#21
|
|||
|
|||
ïóíêöèÿ â ìàå, ïîïðîáóþ íàïðîñèòüñÿ íà ñöèíòèãðàôèþ. ñïàñèáî. âñ¸ æå: êàêèå ïðîãíîçû íà îïåðàöèþ è äàëüíåéøåå ïëàíèðîâàíèå áåðåìåííîñòè?
|
#22
|
||||
|
||||
Âû î ÷åì?
Ñöèíòèãðàôèÿ ñêàæåò, íóæíà ëè ïóíêöèÿ Îáà èññëåäîâàíèÿ èëè îäíî èç íèõ ïîäñêàæåò äèàãíîç, ëå÷åáíûå ìåðîïðèÿòèÿ è ïðîãíîç  ëþáîì ñëó÷àå ïðîãíîç íà áåðåìåííîñòü áëàãîïîëó÷íûé
__________________
Ã.À. Ìåëüíè÷åíêî |
|
#23
|
|||
|
|||
ß Âàì î÷åíü áëàãîäàðíà. çíà÷èò ïåðâûì äåëîì äåëàþ ñöèíòèãðàôèþ. òèðîçîëà òàê æå 30 ìã?
|
#24
|
||||
|
||||
Ìá, óæå 20 - âîïðîñ ê ñâ Ò4 è î÷íîìó âðà÷ó
__________________
Ã.À. Ìåëüíè÷åíêî |
#25
|
|||
|
|||
ïîíÿëà, ñâ ò4- 0,75 (íîðìà 0,80-2.10), çàâòðà ê î÷íîìó âðà÷ó. Áëàãîäàðþ.
|
#26
|
||||
|
||||
Äà, 20
__________________
Ã.À. Ìåëüíè÷åíêî |
#27
|
||||
|
||||
|
#28
|
|||
|
|||
Ñöèíòèãðàôèÿ ïî ãðàôèêó â èþëå, áèîïñèÿ ïîêàçàëà êîëëîèäíûé óçåë. Ïüþ òèðîçîë 20 ìã (ïîñëåäíþþ íåäåëþ ïüþ ïî 10 ìã, ò.ê. ÷àñòî çàáûâàþ), ò4 11.05.2015- 0,52 (0,80-2,10). Áèîïñèþ áðàëè â îáëîíêîäèñïàíñåðå, âðà÷-îíêîëîã ñêàçàë, ÷òî â ñöèíòèãðàôèè íà äàííûé ìîìåíò íåò ðåçêîé íåîáõîäèìîñòè....
|
#29
|
||||
|
||||
Öèòàòà:
Eur J Nucl Med Mol Imaging (2008) 35:1171–1172 Scintigraphy or fine-needle aspiration biopsy to exclude thyroid malignancy: what should be done first in iodine deficiency? C. Reiners "Fine-needle biopsy is recommended to be performed only in patients with cold nodules detected by scintigraphy, which reduces the percentage of nodules to be biopsied to approximately 30%." Áèîïñèÿ ïðîïóñêàåò 30% ðàêîâ ÙÆ. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Ann Surg. 2007 Nov; 246(5):714-20. Fine-needle aspiration may miss a third of all malignancy in palpable thyroid nodules: a comprehensive literature review. |
#30
|
||||
|
||||
 íåöèâèëèçîâàííûõ - òîæå è ïðè ÍÈÇÊÎÌ ÒÒà ( íèæå 2-õ ) ïðîâîäÿò ñöèíòèãðàôèþ äëÿ âûÿâëåíèÿ òåõ ñàìûõ ãîðÿ÷èõ óçëîâ , êîè è íå äóìàþò áûòü çëîêà÷åñâòåííûìè.
Áèîïñèÿ è íå äóìàò ïðîïóñêàòü 30 % ðàêîâ - îíà ÷åñòíî ãîâðèò , ÷òî çäåñü Áåòåñäà 3 èëè 4 ñëåäóþùèé øàã - îïåðàöèÿ êàê çàêëþ÷èòåëüíûé ýòàï äèàãíîñòèêè . Áèîïñèÿ îøèáàåòñÿ ïðè ìåäóëëÿðêå - ïî÷åìó è äåëàåì êàëüöèòîíèí
__________________
Ã.À. Ìåëüíè÷åíêî |